Young Kwon

Join Andrei Georgescu (VivoDyne CEO), Serafim Batzoglou (Seer Chief Data Officer), Dave Longo (Ordaōs CEO), Alex Zhavoronkov (Insilico Medicine Founder), and Young Kwon (Alchemab Therapeutics PhD) as they revolutionize drug R&D. Discover how VivoDyne's bioengineering platform is transforming tissue sample research. Learn about Seer's nanoparticle technologies that unveil more proteins than ever. Uncover Ordaōs' innovative mini-proteins reshaping drug development and the impact of AI on discovering therapies for complex diseases. It's a deep dive into the future of medicine!